适体
纳米技术
可穿戴计算机
计算机科学
生化工程
生物传感器
可穿戴技术
适应(眼睛)
系统工程
生物标志物
风险分析(工程)
信号(编程语言)
计算生物学
药物发现
临床诊断
生物分析
材料科学
合成生物学
作者
Xingxing Li,Li Fu,Fei Chen,Yanfei Lv,Shichao Zhao,Hassan Karimi‐Maleh
摘要
Aptamer‐based electrochemical biosensors have emerged as powerful platforms for point‐of‐care diagnostics by combining the molecular recognition precision of nucleic acid aptamers with the rapid and portable nature of electrochemical detection. This review critically examines how electrochemical signal‐transduction strategies translate aptamer–target interactions into measurable outputs and assesses their readiness for clinical implementation. Diverse signal designs are analyzed with respect to sensitivity, reproducibility, and suitability for miniaturized, reagent‐free testing. Representative applications in infectious‐disease diagnosis, cancer biomarker detection, cardiac and metabolic monitoring, and therapeutic drug measurement demonstrate that aptamer sensors can match or surpass current laboratory assays in analytical performance. Nevertheless, challenges remain in achieving stability in biological matrices, mitigating surface fouling, and ensuring large‐scale manufacturing and regulatory validation. Advances in chemical modifications, antifouling surface engineering, and flexible device architectures, including wearable and implantable formats, are progressively overcoming these barriers. The review also contrasts aptamers with antibodies to highlight niches where aptamer sensors provide unique advantages, such as continuous in vivo monitoring and rapid adaptation to emerging biomarkers. Overall, electrochemical aptamer sensors are approaching a transformative threshold from laboratory innovation to practical clinical diagnostics, marking a critical intersection between biotechnology and electronic sensing that may redefine the future of personalized and decentralized healthcare.
科研通智能强力驱动
Strongly Powered by AbleSci AI